Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
University of Calgary
$120,000.00
Exercise to enhance adoptive (double-negative) T cell therapy for acute myeloid leukemia
EF 2025-26
Résumé
This innovative project explores the potential of exercise to enhance the effectiveness of a novel cancer treatment called adoptive cellular therapy (ACT), with a focus on double-negative T cells (DNTs) as a treatment for acute myeloid leukemia (AML).
ACT involves infusing anti-cancerous immune cells into patients for treatment. Most ACT uses the patient's own immune cells for safety, yet this approach is expensive, limiting patient accessibility. DNT therapy provides a unique solution. Derived from healthy donors, DNTs are safe, easy to use, and highly effective in killing AML without causing harmful side effects. DNTs can be pre-manufactured, enabling an "off-the-shelf" treatment that is more accessible. Early clinical trials using DNT therapy have shown encouraging survival benefits in AML patients, making it a promising treatment with high potential.
Exercise is well-known to strengthen the immune system, which could be linked to its survival benefits in cancer patients. Exercise boosts immune cell fitness, a key feature of successful ACT, and this has the potential to be harnessed to enhance therapeutic outcomes. However, studying the impact of exercise in ACT is difficult as most approaches use the patient's immune cells and implementing structured exercise in individuals battling cancer is challenging. Leveraging the donor-derived nature of DNT therapy, this study addresses this limitation by implementing a pre-donation exercise program performed by healthy donors.
By investigating how exercise improves immune cell function, this study aims to uncover new ways to enhance the effectiveness of DNT therapy, identify novel pathways involved, and address significant challenges in cancer treatment. At a novel intersection of cancer immunotherapy and exercise science, this research will pave the way for new applications of exercise to develop more effective treatments, advancing our understanding of leveraging lifestyle interventions to enhance patient outcomes.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
559831
Name
Lee Heejae
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Exercise to enhance adoptive (double-negative) T cell therapy for acute myeloid leukemia
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Acute Myeloid Leukemia; Adoptive Cellular Therapy; Cancer Immunotherapy; Double-Negative T Cells; Exercise Immunology; Exercise Oncology; Exercise Physiology
Abstract
This innovative project explores the potential of exercise to enhance the effectiveness of a novel cancer treatment called adoptive cellular therapy (ACT), with a focus on double-negative T cells (DNTs) as a treatment for acute myeloid leukemia (AML).
ACT involves infusing anti-cancerous immune cells into patients for treatment. Most ACT uses the patient's own immune cells for safety, yet this approach is expensive, limiting patient accessibility. DNT therapy provides a unique solution. Derived from healthy donors, DNTs are safe, easy to use, and highly effective in killing AML without causing harmful side effects. DNTs can be pre-manufactured, enabling an "off-the-shelf" treatment that is more accessible. Early clinical trials using DNT therapy have shown encouraging survival benefits in AML patients, making it a promising treatment with high potential.
Exercise is well-known to strengthen the immune system, which could be linked to its survival benefits in cancer patients. Exercise boosts immune cell fitness, a key feature of successful ACT, and this has the potential to be harnessed to enhance therapeutic outcomes. However, studying the impact of exercise in ACT is difficult as most approaches use the patient's immune cells and implementing structured exercise in individuals battling cancer is challenging. Leveraging the donor-derived nature of DNT therapy, this study addresses this limitation by implementing a pre-donation exercise program performed by healthy donors.
By investigating how exercise improves immune cell function, this study aims to uncover new ways to enhance the effectiveness of DNT therapy, identify novel pathways involved, and address significant challenges in cancer treatment. At a novel intersection of cancer immunotherapy and exercise science, this research will pave the way for new applications of exercise to develop more effective treatments, advancing our understanding of leveraging lifestyle interventions to enhance patient outcomes.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lee, Heejae
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~